Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $172,437 - $219,224
-1,253 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $165,370 - $205,178
1,253 New
1,253 $203,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $269,127 - $331,906
-3,457 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $318,078 - $425,936
3,457 New
3,457 $327,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $378B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Johnson Financial Group, LLC Portfolio

Follow Johnson Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, LLC with notifications on news.